Michael Polydefkis - Concepedia

Author

Michael Polydefkis

Also Known As

Allison Davis, Daniel Lenihan, David Adams, Emre Altinkurt, Janice F. Wiesman, John L. Berk, Jonas Wixner, M J Polydefkis, M Polydefkis, M. J. Polydefkis

227

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Inserm Boston University Johns Hopkins Hospital

About

Michael Polydefkis is an author at Johns Hopkins University specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	1.5K
2	Health Sciences	3	3	145
3	Engineering	2	2	380
4	Social Sciences	2	2	257
5	Biomedical Engineering	1	1	370

Michael Polydefkis

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis David Adams, Alejandra González‐Duarte, William O’Riordan, New England Journal of Medicine	2018	2.8K
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk, New England Journal of Medicine	2018	1.4K
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society Giuseppe Lauria, Sung‐Tsang Hsieh, O. Johansson, European Journal of Neurology	2010	817
The spectrum of neuropathy in diabetes and impaired glucose tolerance Charlotte J. Sumner, Sanjana Sheth, Justin W. Griffin, Neurology	2003	701
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy Michael Polydefkis, Peter Hauer, Soham Sheth, Brain Tissue EngineeringNormal ControlsEngineeringCapsaicin TreatmentPeripheral Nerve Injury	2004	370
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial David Adams, Ivailo Tournev, Mark Taylor, Amyloid	2022	344
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy Michael Polydefkis, Constantin T. Yiannoutsos, Bruce A. Cohen, Neurology	2002	304
Subclinical sensory neuropathy in late-onset restless legs syndrome Michael Polydefkis, Richard P. Allen, P. Hauer, Neurology	2000	265
Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy Vinay Chaudhry, David R. Cornblath, Michael Polydefkis, Journal of the Peripheral Nervous System Neuro-oncologyPeripheral NeuropathyTherapeutic Drug MonitoringSpinal Cord InjuryDose-limiting Peripheral Neuropathy	2008	171
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study David Adams, Michael Polydefkis, Alejandra González‐Duarte, The Lancet Neurology Alzheimer's DiseaseOpen-label Extension StudyMedicineHereditary Transthyretin-mediated AmyloidosisNeurology	2020	154

Page 1